Angela(Sievert)WaandersMD

Pediatric Hematology & Oncology • Chicago, IL

Pediatric Neuro-Oncology

Associate Professor

Join to view full profile

Dr. Waanders is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Waanders' full profile

Already have an account?

Office
225 E Chicago Ave
Box 30
Chicago, IL 60611
Phone+1 312-227-4939

Fax+1 215-590-3992

Education & Training

Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 2006 - 2009
Children's Hospital of PhiladelphiaResidency, Pediatrics, 2003 - 2006
Tulane University School of MedicineClass of 2003

Certifications & Licensure

IL State Medical License 2018 - 2026
PA State Medical License 2005 - 2021
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology
American Board of Preventive Medicine Clinical Informatics

Clinical Trials

Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas
Available
Roles: Contact
Fimepinostat in Treating Brain Tumors in Children and Young Adults Start of enrollment: 2019 Aug 07
Active, not recruiting
Early Phase 1
Roles: Contact
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021) Start of enrollment: 2020 Dec 09
Recruiting
Phase 1
Roles: Contact
REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma Start of enrollment: 2018 Sep 24
Terminated
Phase 1, Phase 2
Roles: Contact
Post Mortem Tissue Donation of Pediatric Tumor Tissues and Cells Start of enrollment: 2019 Aug 14
Recruiting
Roles: Contact, Principal Investigator
Modified Measles Virus (MV-NIS) for Children and Young Adults With Recurrent Medulloblastoma or Recurrent ATRT Start of enrollment: 2017 Feb 22
Completed
Phase 1
Roles: Contact
A Phase II Trial of Poly-ICLC for Low-Grade Gliomas Start of enrollment: 2021 Dec 15
Recruiting
Phase 2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Socioeconomic Factors Associated With Participation in Postmortem Tissue Donation in Pediatric Central Nervous System Tumors.
Judith M Kabat, Lauren K Boland, Melissa Williams, Ian Michelson, Alicia Lenzen
Pediatric Blood & Cancer. 2024-11-12
2 citations
An International Pediatric-Onset Opsoclonus-Myoclonus Ataxia Syndrome Registry and Clinical Research Network: Development, Progress, and Vision.
Lauren M Kerr, Morgan E Ryan, Ming Lim, Sarah Hearn, Andrea Klein
Pediatric Neurology. 2023-11-01
A multi-institutional pediatric dataset of clinical radiology MRIs by the Children's Brain Tumor Network.
Ariana M Familiar, Anahita Fathi Kazerooni, Hannah Anderson, Aliaksandr Lubneuski, Karthik Viswanathan
Arxiv. 2023-10-02

Journal Articles

Standardization of Prophylactic Platelet Transfusion Dosing in a Pediatric Oncology Population: A Quality Improvement Project
Heather Wolfe, David Friedman, Michele P Lambert, Angela Waanders, Transfusion
Author Correction: The Landscape of Genomic Alterations Across Childhood Cancers
Angela (Sievert) Waanders, MD, Nature

Press Mentions

OpenPBTA: A New Collaborative Effort to Accelerate Discoveries Empowered by the Pediatric Brain Tumor AtlasSeptember 29th, 2019
It Takes a Village: How Clinicians, Researchers, and Patient Families Can Collaborate Toward Cures for Childhood Brain TumorsMay 22nd, 2019
Children’s Brain Tumor Tissue Consortium Launches First-of-Its-Kind Pediatric Brain Tumor AtlasSeptember 10th, 2018
Join now to see all